Skip to content
Alivexis, Inc.
Unveiling the Future of Medicine
Menu
Home
Science
Pipeline
About Us
News
Public Notice
Contact Us
日本語
News
News
39th Annual J.P. Morgan Healthcare Conference - Modulus Discovery Presentation
- 26 January, 2021
Modulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
- 14 December, 2020
Modulus Discovery Announces Signing of a Collaboration Agreement with the University Of Tokyo to Pursue Drug Discovery for COVID-19 and Related Emerging Virus Infections
- 02 October, 2020
Modulus Discovery Receives “Mizuho Innovation Award”
- 28 July, 2020
Modulus Discovery Closes $25.5M USD Series B
- 13 May, 2020
Modulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Inc.
- 30 May, 2019
Modulus Discovery Announces Signing of Collaboration Agreement with Tokyo Institute of Technology
- 09 May, 2019
Modulus Discovery Announces Senior Appointments including Jon Mason as Scientific Advisor
- 28 January, 2019
Modulus Discovery Announces the Initiation of a Research Collaboration with Prof. Tsutomu Suzuki, University of Tokyo
- 31 October, 2018
Modulus Discovery Announces Signing of a Multi-Target Research Collaboration with Professor Osamu Nureki, University of Tokyo
- 04 September, 2018
Previous
Next
Press & Media Contact
Email address protected by JavaScript.
Please enable JavaScript to contact me.
Latest Release
Joint Research on Novel Anti-Allergic Disease Drug Candidate Published by Alivexis, Inc. and University of Yamanashi
Modulus Discovery, Inc. to Change Its Name to Alivexis, Inc. on March 11, 2024
Modulus Discovery, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PeptiDream and Modulus Announce Nomination of First Clinical Development Candidate from Strategic Partnership
Modulus Discovery has been selected as a “J-Startup” company by the Ministry of Economy, Trade and Industry of Japan